Australia markets closed

Evoke Pharma, Inc. (EV00.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
2.02000.0000 (0.00%)
As of 08:12AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) 6.70M
Enterprise value -2.03M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.49
Price/book (mrq)0.89
Enterprise value/revenue -0.93
Enterprise value/EBITDA 0.27

Trading information

Stock price history

Beta (5Y monthly) 0.58
52-week change 3-84.48%
S&P500 52-week change 3-13.66%
52-week high 315.0000
52-week low 31.9144
50-day moving average 32.6736
200-day moving average 34.1290

Share statistics

Avg vol (3-month) 3117
Avg vol (10-day) 3N/A
Shares outstanding 53.34M
Implied shares outstanding 6N/A
Float 82.35M
% held by insiders 12.46%
% held by institutions 12.11%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:12
Last split date 324 May 2022

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)30 June 2022


Profit margin 0.00%
Operating margin (ttm)-348.01%

Management effectiveness

Return on assets (ttm)-29.55%
Return on equity (ttm)-122.36%

Income statement

Revenue (ttm)2.17M
Revenue per share (ttm)0.77
Quarterly revenue growth (yoy)95.20%
Gross profit (ttm)1.29M
Net income avi to common (ttm)-8.05M
Diluted EPS (ttm)-2.8370
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)13.45M
Total cash per share (mrq)4.02
Total debt (mrq)5M
Total debt/equity (mrq)69.53
Current ratio (mrq)10.65
Book value per share (mrq)2.15

Cash flow statement

Operating cash flow (ttm)-10.88M
Levered free cash flow (ttm)-8.36M